ZA968783B - Flupirtine usage - Google Patents
Flupirtine usageInfo
- Publication number
- ZA968783B ZA968783B ZA968783A ZA968783A ZA968783B ZA 968783 B ZA968783 B ZA 968783B ZA 968783 A ZA968783 A ZA 968783A ZA 968783 A ZA968783 A ZA 968783A ZA 968783 B ZA968783 B ZA 968783B
- Authority
- ZA
- South Africa
- Prior art keywords
- flupirtine
- usage
- patients
- prophylaxis
- impairment
- Prior art date
Links
- JUUFBMODXQKSTD-UHFFFAOYSA-N N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester Chemical compound N1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1 JUUFBMODXQKSTD-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003667 flupirtine Drugs 0.000 title abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polyurethanes Or Polyureas (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19541405A DE19541405A1 (de) | 1995-11-07 | 1995-11-07 | Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA968783B true ZA968783B (en) | 1997-05-27 |
Family
ID=7776799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA968783A ZA968783B (en) | 1995-11-07 | 1996-10-18 | Flupirtine usage |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US6034111A (cs) |
| EP (1) | EP0859613B1 (cs) |
| JP (1) | JPH11514652A (cs) |
| KR (1) | KR100512673B1 (cs) |
| CN (1) | CN1116037C (cs) |
| AT (1) | ATE316789T1 (cs) |
| AU (1) | AU711207B2 (cs) |
| BG (1) | BG63149B1 (cs) |
| BR (1) | BR9611588A (cs) |
| CA (1) | CA2189705C (cs) |
| CZ (1) | CZ298115B6 (cs) |
| DE (2) | DE19541405A1 (cs) |
| DK (1) | DK0859613T3 (cs) |
| ES (1) | ES2257755T3 (cs) |
| HU (1) | HU225742B1 (cs) |
| MX (1) | MX9803610A (cs) |
| NO (1) | NO315074B1 (cs) |
| NZ (1) | NZ330414A (cs) |
| PL (1) | PL186537B1 (cs) |
| PT (1) | PT859613E (cs) |
| RU (1) | RU2200555C2 (cs) |
| SK (1) | SK284601B6 (cs) |
| TW (1) | TW393317B (cs) |
| UA (1) | UA51682C2 (cs) |
| WO (1) | WO1997017072A2 (cs) |
| ZA (1) | ZA968783B (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19625582A1 (de) * | 1996-06-27 | 1998-01-02 | Asta Medica Ag | Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen |
| US6821995B1 (en) | 1999-12-01 | 2004-11-23 | Duke University | Method of treating batten disease |
| DE10327674A1 (de) | 2003-06-20 | 2005-01-05 | Awd.Pharma Gmbh & Co. Kg | Injizierbare Darreichungsform von Flupirtin |
| EP1688141A1 (en) * | 2005-01-31 | 2006-08-09 | elbion AG | The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome |
| US20080279930A1 (en) * | 2007-05-07 | 2008-11-13 | Bernd Terhaag | Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof |
| DE102009023162B4 (de) * | 2009-05-29 | 2011-07-07 | Corden PharmaChem GmbH, 68305 | Verfahren zur Herstellung von Flupirtin |
| KR101704849B1 (ko) * | 2009-08-07 | 2017-02-08 | 스와겔로크 컴패니 | 저진공 하에서의 저온 침탄 |
| DE102010030053A1 (de) | 2010-06-14 | 2011-12-15 | Awd.Pharma Gmbh & Co.Kg | Injizierbare Darreichungsform von Flupirtin |
| EA201491477A1 (ru) * | 2012-03-02 | 2015-02-27 | Меда Фарма Гмбх Унд Ко. Кг | Фармацевтические составы, содержащие флупиртин |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN172468B (cs) * | 1990-07-14 | 1993-08-14 | Asta Medica Ag | |
| DE4327516A1 (de) * | 1993-08-17 | 1995-02-23 | Asta Medica Ag | Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin |
-
1995
- 1995-11-07 DE DE19541405A patent/DE19541405A1/de not_active Ceased
-
1996
- 1996-10-18 ZA ZA968783A patent/ZA968783B/xx unknown
- 1996-10-23 DE DE59611327T patent/DE59611327D1/de not_active Expired - Lifetime
- 1996-10-23 RU RU98111152/14A patent/RU2200555C2/ru not_active IP Right Cessation
- 1996-10-23 JP JP9517734A patent/JPH11514652A/ja active Pending
- 1996-10-23 HU HU9901659A patent/HU225742B1/hu not_active IP Right Cessation
- 1996-10-23 UA UA98062946A patent/UA51682C2/uk unknown
- 1996-10-23 KR KR10-1998-0703376A patent/KR100512673B1/ko not_active Expired - Fee Related
- 1996-10-23 PL PL96326629A patent/PL186537B1/pl not_active IP Right Cessation
- 1996-10-23 CZ CZ0128398A patent/CZ298115B6/cs not_active IP Right Cessation
- 1996-10-23 PT PT96945822T patent/PT859613E/pt unknown
- 1996-10-23 DK DK96945822T patent/DK0859613T3/da active
- 1996-10-23 BR BR9611588A patent/BR9611588A/pt not_active Application Discontinuation
- 1996-10-23 CN CN96198131A patent/CN1116037C/zh not_active Expired - Fee Related
- 1996-10-23 NZ NZ330414A patent/NZ330414A/en unknown
- 1996-10-23 AU AU17165/97A patent/AU711207B2/en not_active Ceased
- 1996-10-23 AT AT96945822T patent/ATE316789T1/de active
- 1996-10-23 EP EP96945822A patent/EP0859613B1/de not_active Expired - Lifetime
- 1996-10-23 WO PCT/DE1996/002009 patent/WO1997017072A2/de active IP Right Grant
- 1996-10-23 ES ES96945822T patent/ES2257755T3/es not_active Expired - Lifetime
- 1996-10-23 SK SK586-98A patent/SK284601B6/sk not_active IP Right Cessation
- 1996-11-04 TW TW085113437A patent/TW393317B/zh not_active IP Right Cessation
- 1996-11-06 CA CA002189705A patent/CA2189705C/en not_active Expired - Fee Related
- 1996-11-07 US US08/744,953 patent/US6034111A/en not_active Expired - Lifetime
-
1998
- 1998-04-16 US US09/061,099 patent/US6034112A/en not_active Expired - Lifetime
- 1998-04-24 BG BG102404A patent/BG63149B1/bg unknown
- 1998-04-27 NO NO19981898A patent/NO315074B1/no not_active IP Right Cessation
- 1998-05-07 MX MX9803610A patent/MX9803610A/es not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW376320B (en) | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma | |
| AU5646886A (en) | Therapeutical application of phosphonylmethoxyalkyl adenines | |
| TW371660B (en) | Therapeutic nucleosides a purine carbocyclic nucleosides for treatment of HIV and HBV infections | |
| YU18899A (sh) | L-nukleozidi purina, njihovi analogoni i primena | |
| MY117892A (en) | Therapeutic compounds | |
| IE900073L (en) | Treatment of diseases associated with hiv infections | |
| ZA968783B (en) | Flupirtine usage | |
| DK0855916T3 (da) | Farmaceutisk præparat indeholdende en Activin-stimulator | |
| AP9801286A0 (en) | Therapeutic compounds. | |
| MY105855A (en) | Therapeutic nucleotides. | |
| NZ512850A (en) | Treatment of papillomavirus infections | |
| AU2880595A (en) | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
| AU4111600A (en) | The use of gssg reductase for the therapy and prophylaxis of hiv infected patients | |
| MX9700560A (es) | Metodo de uso de integrasa retroviral negativa transdominante en el tratamiento de infecciones retrovirales. | |
| AU5061090A (en) | Aids therapy | |
| WO1997026880A3 (en) | Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients | |
| AU2396900A (en) | Treatment and prevention of hiv and other viral infections | |
| AU2211592A (en) | Method of treatment for latent virus infection | |
| AU2450900A (en) | Therapeutic nucleoside compound | |
| ES8700940A1 (es) | Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus | |
| WO1988008707A3 (en) | Rubradirin derivatives for treatment of hiv infection | |
| GR950100315A (el) | Φαρμακευτικο παρασκευασμα βασιζομενο σε εναιωρημα εμβρυικων κυτταρων με ανοσοδιορθωτικη δραση και μεθοδος θεραπειας ζαχαρωδους διαβητη με τη χρηση αυτου του παρασκευασματος. | |
| MX9503363A (es) | N-(2,6-dioxo-3-piperidil) ftalimida (generico talidomida como tratamiento del sindrome de desgaste asociado con la infeccion por vih-1. | |
| AU2880495A (en) | Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
| MY102905A (en) | Therapeutic nucleosides |